Pharmafile Logo
Pharmafocus logo
Advanced Search
Roche picture

FDA grants Roche’s pertuzumab priority review

February 10, 2012
Sales and Marketing Herceptin, Roche, pertuzumab

The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …

News
Michael Quiqueran-Beaujeu (left) and João Rocha

Lundbeck appoints European leaders

February 10, 2012
Medical Communications, Sales and Marketing Cipralex, Lundbeck

Lundbeck has appointed two new regional vice presidents for European markets, in time for new drug launches.João Rocha is to …

News

PR agencies warn of ‘race to the bottom’

February 10, 2012
Medical Communications HCA, PR

A new survey of PR agencies working in healthcare has highlighted concerns about cost-cutting which they say could lower standards …

News

Value destruction: pharma has only itself to blame

February 10, 2012
R&D productivity

Pharma has only itself to blame for destroying value from its R&D pipeline, according to Andrew Baum, managing director of …

News

MPs support health and social care integration

February 10, 2012
Sales and Marketing NHS, social care

The integration of care services will help improve outcomes for older people and those with disabilities and long-term conditions, according …

News
tim_watts

Oxford BioMedica makes management change

February 10, 2012
Research and Development, Sales and Marketing Oxford BioMedica

Gene-based biopharmaceutical firm Oxford BioMedica has announced that Andrew Wood, chief financial officer, has stepped down from the board of Oxford …

Appointment

Chiltern welcomes Gastroenterology, Oncology and Pediatric Therapeutic experts to their team

February 9, 2012
Research and Development

 Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Drs. Marcelo Piccirillo and Carlo Lanza have joined …

News
Press release
MEP image

Doctors, medical education and pharma – the way ahead

February 9, 2012
Medical Communications ABPI, ASME, CME, Continuing medical education, GMC, MEP

 InPharm CME event Roy Pounder, Andrew Powrie-Smith, Richard Marchant, Roy Lilley, Kieran Walsh and Chuka Nwokolo are all speakers at …

Feature

Regulis win the TOPRA* Award for Support

February 9, 2012
Research and Development

News
Press release

European Medicines Agency and European Food Safety Authority commit to a stronger collaboration

February 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have agreed to work closer together on areas …

News
Press release

Bayer UK/Ireland appoints new chief financial officer

February 9, 2012
Business Services, Sales and Marketing Bayer, Ute Bockstegers

Bayer has appointed Ms Ute Bockstegers as chief financial officer and head of business administration and partnering.Ute Bockstegers comes to …

Appointment

Fate of Merck’s vorapaxar still unclear

February 8, 2012
Medical Communications, Sales and Marketing Merck, vorapaxar

Merck & Co’s blood thinner vorapaxar, designed to prevent blood clots and reduce heart attacks, is still causing bleeding in …

News

New drug discounts should be made transparent

February 8, 2012
Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing

Patient access schemes agreed through NICE should be made more transparent.  This is according to Paul McManus, a pharmacist and …

News
GSK picture

GSK posts strong underlying sales growth

February 8, 2012
Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix

GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead.  The UK firm saw 4% …

News

Hospira appoints Richard Davies as chief commercial officer

February 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hospira, Richard Davies

Hospira has announced Richard Davies as its senior vice president and chief commercial officer. In this role, he will be responsible for …

Appointment
Breast cancer image

Breast cancer treatment – the next advances

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Afinitor, CDF, Lorena Tonarelli, T-DM1, breast cancer, pertuzumab

When a close member of my family was diagnosed with breast cancer, the doctors didn’t give us much hope. They …

Feature

Merck prepares insomnia candidate

February 7, 2012
Sales and Marketing Merck, insomnia

Merck is to file its new insomnia drug suvorexant, with US regulators later this year. Suvorexant is an orexin receptor …

News

Dr Stephen Rosevear joins Cogent as director of Research & Policy

February 7, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cogent, Stephen Rosevear

Prior to joining Cogent, Stephen was HMRC’s chief analyst on the corporate real estate market, undertaking tax modeling and policy development for …

Appointment

GSK earmarks $60m for Australian plant

February 7, 2012

News

US bill tries to tackle medicine shortages

February 7, 2012

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026